Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Sept 2002

Darwish H, Trejo I E, Shapira I, Oweineh S, Sughayer M, Baron L, Aljadeff E, Silbermann M, Sweidan W, Zilberg D, Halpern Z, Hibshoosh H, Arber N

Abstract excerpt

BACKGROUND: To evaluate and compare differences in the molecular genetics among high-risk (Ashkenazi Jews), intermediate-risk (Sephardic Jews) and low-risk (Palestinians) groups for colorectal cancer who live in the same geographical region. PATIENTS AND METHODS: The 1995-1996 records from the Te...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arabs
Share to beta Catenin
Share to Biopsy, Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin D1

Share to Israel

Share to Ki-67 Antigen

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 12196377
DOI: 10.1093/annonc/mdf230

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12196377-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fighting colorectal cancer: molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians.PMID 12196377Read ↗

Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations.Semantic proximity Read ↗

Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.Semantic proximity Read ↗

Cancer in Jews: introduction and overview.Semantic proximity Read ↗

Ethnic differences in cancer risk resulting from genetic variation.Semantic proximity Read ↗

The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.Semantic proximity Read ↗

The changing incidence and sites of colorectal cancer in the Israeli Arab population and their clinical implications.Semantic proximity Read ↗

Genetic factors and colorectal cancer in Ashkenazi Jews.Semantic proximity Read ↗

The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.Semantic proximity Read ↗

Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.Semantic proximity Read ↗

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.Semantic proximity Read ↗

Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women.Semantic proximity Read ↗

Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.